As a leading full service CRO, PSI provides the services required to support global clinical trials, offering in-depth therapeutic experience across Phase I-IV clinical programs. We provide you with the expertise that is needed to conduct your clinical trial, whether it is a Phase I study, proof-of-concept or rescuing a pivotal study where enrollment is behind schedule; our goal is to complete your study on time!
For CNS studies, where competition for patients and complexity of design are leading characteristics, we apply our years of experience and relationships with investigators to manage and support their efforts to meet enrollment goals.
PSI has successfully performed Phase II/III studies in the following CNS indications:
- Alzheimer's disease
- Diabetic neuropathy
- Narcolepsy
- Insomnia
- Post-stroke spasticity
|
- Depression
- CVD (including TIA and stroke)
- Generalized anxiety disorder
- Schizophrenia
|
- Smoking cessation
- Multiple sclerosis
- Opioid dependence
- Parkinson's Dementia
|
PSI consistently employs physicians as full-time monitors and project managers. Most of this team are board certified specialists, including neurologists, psychiatrists, and pediatric psychiatrists. This provides PSI with the insight necessary to deliver on CNS clinical trial patient enrollment.
Case Study Examples: Schizophrenia Clinical Trial, Multiple Sclerosis Clinical Trial, Parkinson's Dementia Clinical Trial, Opioid Dependence Clinical Trial
